DRAGON 2 - An international multicenter randomized controlled trial to compare combined Portal and Hepatic Vein Embolization (PVE/HVE) with PVE alone in liver surgery

DRAGON 2 - 一项国际多中心随机对照试验，比较肝脏手术中联合门静脉和肝静脉栓塞术 (PVE/HVE) 与单独 PVE 的效果

• 批准号: 463216
• 负责人: Martel Guillaume
• 金额: $ 46.83万
• 依托单位: Ottawa Hospital Research Institute
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2022
• 资助国家: 加拿大
• 起止时间: 2022-03-01 至 2028-03-01
• 项目状态: 未结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=463216&lang=en
• 关键词: Hepatectomy; Hepatic Vein Embolization; Interventional Radiology; Liver; Metastatic Colorectal Cancer; Portal Vein Embolization; Randomized Controlled Trial; Regeneration; Resectability; Survival

Patients who suffer from colorectal cancer that has spread to the liver (metastases) can be treated with liver surgery. Liver surgery is the most effective treatment in improving survival for this disease, and up to 30% of patients can be cured. Liver sur

患有已经扩散到肝脏（转移）的结直肠癌的患者可以接受肝脏手术治疗。肝脏手术是提高这种疾病生存率的最有效治疗方法，高达30%的患者可以治愈。肝硬化